神经肿瘤患者脑室腹腔分流阀故障的历史队列研究
该历史队列研究回顾2011至2016年接受脑室腹腔分流术的成人脑积水患者,比较脑肿瘤患者(A组89例)与非肿瘤患者(B组164例)的阀门故障翻修风险。中位随访17个月,A组阀门故障显著多于B组(10例 vs 1例,P<0.001),且A组脑脊液蛋白更高,阀门故障者脑脊液蛋白水平是A组其他分流故障者的3倍。
要点
- 脑肿瘤患者分流阀故障风险显著高于非肿瘤患者。
- 阀门故障者脑脊液蛋白水平显著高于其他类型分流故障者。
- 高脑脊液蛋白的脑肿瘤分流患者需密切观察以便紧急翻修。
核心结论
- 分流故障主要发生于脑肿瘤且脑脊液蛋白高的患者,这类患者阀门故障风险高,应密切观察以便紧急阀门翻修。
研究设计与样本
- 历史队列研究,回顾2011至2016年接受脑室腹腔分流术的成人脑积水患者病历,A组为脑肿瘤患者89例,B组为非肿瘤患者164例。
- 中位随访时间全队列17个月,A组9.4个月,B组25个月(P<0.001)。
主要发现
- 60例(23.7%)接受分流翻修,其中11例因阀门故障需更换阀门。
- 阀门故障在A组显著更常见(A组10例 vs B组1例,P<0.001)。
- 非阀门原因的近端或远端分流翻修率两组相似。
- A组脑脊液蛋白水平显著更高(44.5 mg/dL vs 27.79 mg/dL,P<0.05)。
- 阀门故障者脑脊液蛋白水平是A组发生任何类型分流故障者的3倍(96.3 mg/dL vs 30.6 mg/dL,P<0.05)。
临床怎么用
- 对脑肿瘤合并高脑脊液蛋白的分流患者应警惕阀门故障,密切随访以便紧急阀门翻修。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate malfunctioning of ventriculoperitoneal shunt (VPS) valves in patients with brain tumors compared with patients with VPS for nontumoral etiologies to identify risk factors for shunt malfunction. METHODS: Medical charts of all adult patients who underwent VPS surgery for hydrocephalus between 2011 and 2016 were reviewed. Incidence and risk factors for revision surgery due to valve malfunction were identified in patients with brain tumors (group A) and patients without brain tumors (group B). RESULTS: Group A comprised 89 patients, and group B comprised 164 patients. The median follow-up time was 17 months for the entire cohort (9.4 months for group A vs. 25 months for group B, P < 0.001). VPS revision was performed in 60 patients (23.7%); 11 revisions involved valve failures necessitating valve replacement. Valve failures were significantly more common in group A (10 group A patients vs. 1 group B patient, P < 0.001). The distal or proximal shunt revision rate for reasons other than the valve was similar for both groups. Group A patients had a significantly higher cerebrospinal fluid protein level (44.5 mg/dL vs. 27.79 mg/dL, P < 0.05), and patients with valve failure had a 3-fold higher cerebrospinal fluid protein level compared with group A patients who experienced any type of shunt failure (96.3 mg/dL vs. 30.6 mg/dL, P < 0.05). CONCLUSIONS: Shunt malfunction occurred mainly in patients with brain tumors and high cerebrospinal fluid protein levels. These patients are at high risk of valve failure and should be closely observed for emergent valve revision.
引用
- Richetta C, Shofty B, Gurevich A, et al. Valve Failure in Ventriculoperitoneal Shunts of Neuro-Oncologic Patients: A Historical Cohort Study. World Neurosurg. 2019. PMID: 31028985. doi:10.1016/j.wneu.2019.04.144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。